{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:47:36Z","timestamp":1791827256833,"version":"4.3.4"},"reference-count":101,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,16]],"date-time":"2020-01-16T00:00:00Z","timestamp":1579132800000},"content-version":"vor","delay-in-days":3424,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA111882"],"award-info":[{"award-number":["R01 CA111882"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001282","name":"Ovarian Cancer Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001282","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.2353\/ajpath.2010.100105","type":"journal-article","created":{"date-parts":[[2010,7,22]],"date-time":"2010-07-22T23:42:28Z","timestamp":1279842148000},"page":"1053-1064","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1464,"title":["Ovarian Cancer Development and Metastasis"],"prefix":"10.1016","volume":"177","author":[{"given":"Ernst","family":"Lengyel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.2353\/ajpath.2010.100105_bib1","first-page":"225","article-title":"Cancer statistics, 2009","volume":"59","author":"Jemal","year":"2009","journal-title":"CA Cancer J Clin"},{"key":"10.2353\/ajpath.2010.100105_bib2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1006\/gyno.2001.6232","article-title":"The clinical significance of occult macroscopically positive retroperitoneal nodes in patients with epithelial ovarian cancer","volume":"82","author":"Eisenkop","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.2353\/ajpath.2010.100105_bib3","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S1072-7515(03)00478-2","article-title":"Radical oophorectomy with primary stapled colorectal anastomosis for resection of locally advanced epithelial ovarian cancer","volume":"197","author":"Bristow","year":"2003","journal-title":"J Am Coll Surg"},{"key":"10.2353\/ajpath.2010.100105_bib4","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1200\/JCO.2002.20.5.1248","article-title":"Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis","volume":"20","author":"Bristow","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.2353\/ajpath.2010.100105_bib5","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1200\/JCO.2006.10.2517","article-title":"Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group study","volume":"25","author":"Winter","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.2353\/ajpath.2010.100105_bib6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1056\/NEJMoa052985","article-title":"Intraperitoneal cisplatin and paclitaxel in ovarian cancer","volume":"353","author":"Armstrong","year":"2006","journal-title":"N Engl J Med"},{"key":"10.2353\/ajpath.2010.100105_bib7","series-title":"Tumors of the Breast and Female Genital Organs","first-page":"113","article-title":"Tumors of the ovary and peritoneum","author":"Tavassoli","year":"2003"},{"key":"10.2353\/ajpath.2010.100105_bib8","doi-asserted-by":"crossref","first-page":"6116","DOI":"10.1158\/1078-0432.CCR-04-2509","article-title":"Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon","volume":"11","author":"Marquez","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.2353\/ajpath.2010.100105_bib9","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1097\/00006254-197211000-00001","article-title":"Factors in the causation and incidence of ovarian cancer","volume":"27","author":"Fathalla","year":"1972","journal-title":"Obstetr Gynecol Survey"},{"key":"10.2353\/ajpath.2010.100105_bib10","first-page":"281","article-title":"The biology of ovarian cancer","volume":"25","author":"Auersperg","year":"1998","journal-title":"Semin Oncol"},{"key":"10.2353\/ajpath.2010.100105_bib11","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nm1230","article-title":"Lineage infidelity of epithelial ovarian cancers is controlled by HOX genes that specify regional identity in the reproductive tract","volume":"11","author":"Cheng","year":"2008","journal-title":"Nat Med"},{"key":"10.2353\/ajpath.2010.100105_bib12","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.4161\/cc.4.8.1906","article-title":"Developmental patterning in the wrong context: the paradox of epithelial ovarian cancer","volume":"4","author":"Naora","year":"2005","journal-title":"Cell Cycle"},{"key":"10.2353\/ajpath.2010.100105_bib13","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/path.1000","article-title":"Diagnostic changes in prophylactically removed fallopian tubes of women predisposed to developing ovarian cancer","volume":"195","author":"Piek","year":"2001","journal-title":"J Pathol"},{"key":"10.2353\/ajpath.2010.100105_bib14","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1200\/JCO.2005.04.109","article-title":"Risk-reducing salpingo-ophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy","volume":"23","author":"Powell","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.2353\/ajpath.2010.100105_bib15","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","article-title":"Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship","volume":"31","author":"Kindelberger","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.2353\/ajpath.2010.100105_bib16","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ygyno.2009.01.013","article-title":"Precursor to pelvic serous carcinoma and their clinical implications","volume":"113","author":"Folkins","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.2353\/ajpath.2010.100105_bib17","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S1470-2045(08)70308-5","article-title":"The cell of origin of ovarian epithelial tumors","volume":"9","author":"Dubeau","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.2353\/ajpath.2010.100105_bib18","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ygyno.2008.05.031","article-title":"The origin of ovarian carcinomas: a developmental view","volume":"110","author":"Auersperg","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.2353\/ajpath.2010.100105_bib19","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/PAS.0b013e3181cf3d79","article-title":"The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory","volume":"34","author":"Kurman","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.2353\/ajpath.2010.100105_bib20","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/jnci\/95.6.484","article-title":"Mutations in B-raf and K-ras characterize the development of low-grade ovarion serous carcinoma","volume":"95","author":"Singer","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.2353\/ajpath.2010.100105_bib21","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0002-9440(10)63708-X","article-title":"Ovarian tumorigenesis: a proposed model based on morpholgical and molecular genetic analysis","volume":"164","author":"Shih","year":"2004","journal-title":"Am J Pathol"},{"key":"10.2353\/ajpath.2010.100105_bib22","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/01.AOG.0000227787.24587.d1","article-title":"Clinical behavior of stage II-IV low-grade serous carcinoma of the ovary","volume":"108","author":"Gershenson","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.2353\/ajpath.2010.100105_bib23","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0092-8674(00)81333-1","article-title":"Lessons from hereditary colorectal cancer","volume":"87","author":"Kinzler","year":"1996","journal-title":"Cell"},{"key":"10.2353\/ajpath.2010.100105_bib24","doi-asserted-by":"crossref","first-page":"6432","DOI":"10.1158\/1078-0432.CCR-04-0893","article-title":"Characterization of active mitogen-activated protein kinase in ovarian serous carcinomas","volume":"10","author":"Hsu","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.2353\/ajpath.2010.100105_bib25","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/ijc.21845","article-title":"Molecular genetic evidence that endometriosis is a precursor of ovarian cancer","volume":"1189","author":"Prowse","year":"2006","journal-title":"Int J Cancer"},{"key":"10.2353\/ajpath.2010.100105_bib26","article-title":"The molecular signature of endometriosis-associated endometroid ovarian cancer differs significantly from endometriosis-independent endometroid ovarian cancer","author":"Banz","year":"2009","journal-title":"Fertil Steril"},{"key":"10.2353\/ajpath.2010.100105_bib27","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/nm1173","article-title":"Role of K-ras and PTEN in the development of mouse models of endometriosis and endometrioid ovarin cancer","volume":"11","author":"Dinulescu","year":"2005","journal-title":"Nat Med"},{"key":"10.2353\/ajpath.2010.100105_bib28","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1158\/1940-6207.CAPR-08-0236","article-title":"Effects of oral contraceptives or a gonadotropin-releasing hormone agonist on ovarian carcinogenesis in genetically engineered mice","volume":"2","author":"Romero","year":"2009","journal-title":"Cancer Prev Res"},{"key":"10.2353\/ajpath.2010.100105_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pmed.1000114","article-title":"The preclinical natural history of serous ovarian cancer: defining the target for early detection","volume":"6","author":"Brown","year":"2009","journal-title":"PLoS Med"},{"key":"10.2353\/ajpath.2010.100105_bib30","doi-asserted-by":"crossref","first-page":"4036","DOI":"10.1158\/0008-5472.CAN-08-3913","article-title":"Analysis of DNA copy number alterations in ovarian serous tumors identified new molecular genetic changes in low-grade and high-grade carcnomas","volume":"69","author":"Kuo","year":"2009","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2010.100105_bib31","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1755-8794-2-21","article-title":"High resolution analysis of copy number alterations and associated expression changes in ovarian tumors","volume":"2","author":"Haverty","year":"2009","journal-title":"BMC Med Genomics"},{"key":"10.2353\/ajpath.2010.100105_bib32","first-page":"3459","article-title":"Induction of carcinogenesis by concurrent inactivation of p53 and Rb1 in the mouse ovarian surface epithelium","volume":"63","author":"Flesken-Nikitin","year":"2003","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2010.100105_bib33","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1093\/jnci\/85.18.1513","article-title":"Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancer","volume":"85","author":"Kohler","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.2353\/ajpath.2010.100105_bib34","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/01.pas.0000146025.91953.8d","article-title":"Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: a mutational analysis with immunohistochemical correlation","volume":"29","author":"Singer","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.2353\/ajpath.2010.100105_bib35","first-page":"2128","article-title":"p53 mutation is a common genetic event in ovarian carcinoma","volume":"53","author":"Milner","year":"1993","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2010.100105_bib36","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S1470-2045(03)01139-2","article-title":"Why did p53 gene therapy fail in ovarian cancer?","volume":"4","author":"Zeimet","year":"2003","journal-title":"Lancet Oncol"},{"key":"10.2353\/ajpath.2010.100105_bib37","doi-asserted-by":"crossref","first-page":"9267","DOI":"10.1073\/pnas.89.19.9267","article-title":"AKT2, a putative oncogene encoding a member of a subfamily of protein-serine\/threonine kinases, is amplified in human ovarain carcinomas","volume":"89","author":"Cheng","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.2353\/ajpath.2010.100105_bib38","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/5042","article-title":"PIK3CA is implicated as an oncogene in ovarian cancer","volume":"21","author":"Shayesteh","year":"1999","journal-title":"Nat Genet"},{"key":"10.2353\/ajpath.2010.100105_bib39","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.2353\/ajpath.2009.081000","article-title":"Frequent activating mutations of PIK3CA in ovarian clear cell carcinoma","volume":"174","author":"Kuo","year":"2009","journal-title":"Am J Pathol"},{"key":"10.2353\/ajpath.2010.100105_bib40","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.cell.2006.11.001","article-title":"Cancer metastasis: building a framework","volume":"127","author":"Gupta","year":"2006","journal-title":"Cell"},{"key":"10.2353\/ajpath.2010.100105_bib41","first-page":"3584","article-title":"Mechanism of human tumor metastasis studied in patients with peritoneovenous shunts","volume":"44","author":"Tarin","year":"1984","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2010.100105_bib42","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ceb.2005.08.001","article-title":"Molecular requirements for epithelial-mesenchymal transition during tumor progression","volume":"17","author":"Huber","year":"2006","journal-title":"Curr Opin Cell Biol"},{"key":"10.2353\/ajpath.2010.100105_bib43","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nrc1276","article-title":"Cell adhesion and signalling by cadherins and IG-cams in cancer","volume":"4","author":"Cavallaro","year":"2004","journal-title":"Nat Rev"},{"key":"10.2353\/ajpath.2010.100105_bib44","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1172\/JCI39104","article-title":"The basics of epithelial-mesenchymal transition","volume":"119","author":"Kalluri","year":"2009","journal-title":"J Clin Invest"},{"key":"10.2353\/ajpath.2010.100105_bib45","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/ijc.2910580315","article-title":"Differential expression of the cell-cell adhesion molecule E-cadherin in ascites and solid human ovarian tumor cells","volume":"58","author":"Veatch","year":"1994","journal-title":"Int J Cancer"},{"key":"10.2353\/ajpath.2010.100105_bib46","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/S0046-8177(97)90007-1","article-title":"Expression of cadherins in benign, borderline, and malignant ovarian epithelial tumors: a clinicopathologic study of 60 cases","volume":"28","author":"Darai","year":"1997","journal-title":"Hum Pathol"},{"key":"10.2353\/ajpath.2010.100105_bib47","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1002\/cncr.20946","article-title":"Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma","volume":"103","author":"Elloul","year":"2005","journal-title":"Cancer"},{"key":"10.2353\/ajpath.2010.100105_bib48","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/jcp.21240","article-title":"Epithelial-mesenchymal interconversions in normal ovarian surface epithelium and ovarian carcinomas: an exception to the norm","volume":"213","author":"Ahmed","year":"2007","journal-title":"J Cell Physiol"},{"key":"10.2353\/ajpath.2010.100105_bib49","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s10585-008-9171-5","article-title":"Phenotypic plasticity of neoplastic ovarian epithelium: unique cadherin profiles in tumor progression","volume":"25","author":"Hudson","year":"2008","journal-title":"Clin Exp Metastasis"},{"key":"10.2353\/ajpath.2010.100105_bib50","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/ijc.11086","article-title":"Cadherin switching in ovarian cancer progression","volume":"106","author":"Patel","year":"2003","journal-title":"Int J Cancer"},{"key":"10.2353\/ajpath.2010.100105_bib51","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/S0002-9440(10)63501-8","article-title":"Hypoxia attenuates the expression of E-cadherin via up-regulation of SNAIL in ovarian carcinoma cells","volume":"163","author":"Imai","year":"2003","journal-title":"Am J Pathol"},{"key":"10.2353\/ajpath.2010.100105_bib52","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1158\/0008-5472.CAN-06-2808","article-title":"Engagement of collagen-binding integrins promotes matrix metalloproteinase-9-dependent E-cadherin ectodomain shedding in ovarian carcinoma cells","volume":"67","author":"Symowicz","year":"2007","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2010.100105_bib53","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s10585-004-5768-5","article-title":"Ovarian carcinoma spheroids disaggregate on type I collagen and invade live human mesothelial cell monolayers","volume":"21","author":"Burleson","year":"2004","journal-title":"Clin Exp Metastasis"},{"key":"10.2353\/ajpath.2010.100105_bib54","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1158\/0008-5472.CAN-06-1147","article-title":"C-Met overexpression is a prognostic factor in ovarian cancer and an effective target for inhibition of peritoneal dissemination and invasion","volume":"67","author":"Sawada","year":"2007","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2010.100105_bib55","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMra041842","article-title":"Cancer of the ovary","volume":"351","author":"Cannistra","year":"2004","journal-title":"N Engl J Med"},{"key":"10.2353\/ajpath.2010.100105_bib56","first-page":"5721","article-title":"Vascular endothelial growth factor-Trap decreases tumor burden, inhibits ascites, and causes dramtic vascular remodeling in an ovarian cancer model","volume":"9","author":"Byrne","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.2353\/ajpath.2010.100105_bib57","doi-asserted-by":"crossref","first-page":"6966","DOI":"10.1158\/1078-0432.CCR-05-0910","article-title":"Vascular endothelial growth factor Trap combined with paclitaxel strikingly inhibits tumor and ascites, prolonging survival in a human ovarian cancer model","volume":"11","author":"Hu","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.2353\/ajpath.2010.100105_bib58","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ygyno.2003.12.034","article-title":"Ovarian carcinoma ascites spheroids adhere to extracellular matrix components and mesothelial cell monolayers","volume":"93","author":"Burleson","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.2353\/ajpath.2010.100105_bib59","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1477-3163-6-11","article-title":"\u03b12\u03b21-Integrin affects metastatic potential of ovarian carcinoma spheroids by supporting disaggregation and proteolysis","volume":"6","author":"Shield","year":"2007","journal-title":"J Carcinog"},{"key":"10.2353\/ajpath.2010.100105_bib60","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1016\/S0002-9440(10)63058-1","article-title":"\u03b21-Integrins regulate the formation and adhesion of ovarian carcinoma multicellular spheroids","volume":"159","author":"Casey","year":"2001","journal-title":"Am J Pathol"},{"key":"10.2353\/ajpath.2010.100105_bib61","doi-asserted-by":"crossref","first-page":"7121","DOI":"10.1158\/0008-5472.CAN-08-4151","article-title":"Ovarian cancer cell detachment and multicellular aggregate formation are regulated by membrane type 1 matrix metalloproteinase: a potential role in I.p metastatic dissemination","volume":"69","author":"Moss","year":"2009","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2010.100105_bib62","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1309\/B1YX-L8DB-TGY1-7905","article-title":"Expression of membrane-type 1, 2, and 3 matrix metalloproteinases messenger RNA in ovarian carcinoma cells in serous effusion","volume":"115","author":"Davidson","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"10.2353\/ajpath.2010.100105_bib63","first-page":"2388","article-title":"Abrogation of Taxol-induced G2-M arrest and apoptosis in human ovarian cancer cells grown as multicellular spheroids","volume":"57","author":"Frankel","year":"1997","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2010.100105_bib64","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1158\/1535-7163.149.3.2","article-title":"Antiadhesive antibodies targeting E-cadherin sensitize multicellular tumor spheroids to chemotherapy in vitro","volume":"3","author":"Green","year":"2004","journal-title":"Mol Cancer Ther"},{"key":"10.2353\/ajpath.2010.100105_bib65","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/jso.21288","article-title":"Intra-abdominal tumor dissemination pattern and surgical outcome in 214 patients with primary ovarian cancer","volume":"99","author":"Sehouli","year":"2009","journal-title":"J Surg Oncol"},{"key":"10.2353\/ajpath.2010.100105_bib66","first-page":"277","article-title":"Pathology of the peritoneum: a review of selected topics","volume":"8","author":"Daya","year":"1991","journal-title":"Semin Diagn Pathol"},{"key":"10.2353\/ajpath.2010.100105_bib67","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/ijc.22874","article-title":"Use of a novel 3D culture model to elucidate the role of mesothelial cells, fibroblasts and extra-cellular matrices on adhesion and invasion of ovarian cancer cells","volume":"121","author":"Kenny","year":"2007","journal-title":"Int J Cancer"},{"key":"10.2353\/ajpath.2010.100105_bib68","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S1071-5576(01)00122-8","article-title":"Composition of the extracellular matrix of the peritoneum","volume":"8","author":"Witz","year":"2001","journal-title":"J Soc Gynecol Investig"},{"key":"10.2353\/ajpath.2010.100105_bib69","series-title":"Ovarian Cancer","first-page":"335","article-title":"Organotypic models of metastasis: a three dimensional culture mimicking the human peritoneum and omentum for the study of the early steps of ovarian cancer metastasis","author":"Kenny","year":"2009"},{"key":"10.2353\/ajpath.2010.100105_bib70","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1172\/JCI33775","article-title":"The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin","volume":"118","author":"Kenny","year":"2008","journal-title":"J Clin Invest"},{"key":"10.2353\/ajpath.2010.100105_bib71","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1006\/gyno.1999.5388","article-title":"\u03b21-Integrins partly mediate binding of ovarian cancer cells to peritoneal mesothelium in vitro","volume":"73","author":"Strobel","year":"1999","journal-title":"Gynecol Oncol"},{"key":"10.2353\/ajpath.2010.100105_bib72","first-page":"49","article-title":"Vascular cell adhesion molecule-1 is a regulator of ovarian cancer peritoneal metastasis","volume":"33","author":"Slack-Davis","year":"2009","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2010.100105_bib73","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1006\/gyno.1995.1214","article-title":"Expression and function of \u03b21 and \u03b1v\u03b23 integrins in ovarian cancer","volume":"58","author":"Cannistra","year":"1995","journal-title":"Gynecol Oncol"},{"key":"10.2353\/ajpath.2010.100105_bib74","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1016\/j.biocel.2008.05.014","article-title":"Integrin \u03b1v\u03b23 mediates up-regulation of epidermal growth-factor receptor expression and activity in human ovarian cancer cells","volume":"40","author":"L\u00f6ssner","year":"2008","journal-title":"Int J Biochem Cell Biol"},{"key":"10.2353\/ajpath.2010.100105_bib75","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.2353\/ajpath.2009.090028","article-title":"\u03b23-Integrin expression on tumor cells inhibits tumor progression, reduces metastasis, and is associated with a favorable prognosis in patients with ovarian cancer","volume":"175","author":"Kaur","year":"2009","journal-title":"Am J Pathol"},{"key":"10.2353\/ajpath.2010.100105_bib76","first-page":"3830","article-title":"Binding of ovarian cancer cells to peritoneal mesothelium in vitro is partly mediated by CD44H","volume":"53","author":"Cannistra","year":"1993","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2010.100105_bib77","first-page":"1228","article-title":"In vivo inhibition of CD44 limits intra-abdominal spread of a human ovarian cancer xenograft in nude mice: a novel role for CD 44 in the process of peritoneal implantation","volume":"57","author":"Strobel","year":"1997","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2010.100105_bib78","doi-asserted-by":"crossref","first-page":"683","DOI":"10.4161\/cc.8.5.7703","article-title":"MMP-2 functions as an early response protein in ovarian cancer metastasis","volume":"8","author":"Kenny","year":"2009","journal-title":"Cell Cycle"},{"key":"10.2353\/ajpath.2010.100105_bib79","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1093\/jnci\/94.15.1134","article-title":"Contributions of stromal metalloproteinase-9 to angiogenesis and growth of human ovarian carcinoma in mice","volume":"94","author":"Huang","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.2353\/ajpath.2010.100105_bib80","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1038\/sj.bjc.6601635","article-title":"Tumor-induced apoptosis in human mesothelial cells: a mechanism of peritoneal invasion by Fas Ligand\/Fas interaction","volume":"90","author":"Heath","year":"2004","journal-title":"Br J Cancer"},{"issue":"7297","key":"10.2353\/ajpath.2010.100105_bib81","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/nature09075","article-title":"CD95\/Fas promotes tumor growth","volume":"465","author":"Chen","year":"2010","journal-title":"Nature"},{"key":"10.2353\/ajpath.2010.100105_bib82","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/(SICI)1097-0215(19960904)67:5<695::AID-IJC18>3.0.CO;2-4","article-title":"Evidence for preferential adhesion of ovarian epithelial carcinoma cells to type I collagen mediated by the \u03b12\u03b21 integrin","volume":"67","author":"Moser","year":"1996","journal-title":"Int J Cancer"},{"key":"10.2353\/ajpath.2010.100105_bib83","doi-asserted-by":"crossref","first-page":"5849","DOI":"10.1158\/0008-5472.CAN-07-6130","article-title":"Clinical and biological significance of tissue transglutaminase in ovarian carcinoma","volume":"68","author":"Hwang","year":"2008","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2010.100105_bib84","doi-asserted-by":"crossref","first-page":"7194","DOI":"10.1158\/0008-5472.CAN-07-0307","article-title":"Enhanced peritoneal ovarian tumor dissemination by tissue transglutaminase","volume":"67","author":"Satpathy","year":"2007","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2010.100105_bib85","doi-asserted-by":"crossref","first-page":"15390","DOI":"10.1074\/jbc.M808331200","article-title":"Tissue transglutaminase regulates matrix metalloproteinase-2 in ovarian cancer by modulating cAMP-response element-binding protein activity","volume":"284","author":"Satpathy","year":"2009","journal-title":"J Biol Chem"},{"key":"10.2353\/ajpath.2010.100105_bib86","doi-asserted-by":"crossref","first-page":"9192","DOI":"10.1158\/0008-5472.CAN-09-1257","article-title":"Epithelial-to-mesenchymal transition and ovarian tumor progression induced by tissue transglutaminase","volume":"69","author":"Shao","year":"2009","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2010.100105_bib87","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1002\/cncr.20449","article-title":"Vascular endothelial growth factor C and vascular endothelial growth factor receptor 2 are related closely to the prognosis of patients with ovarian carcinoma","volume":"101","author":"Nishida","year":"2004","journal-title":"Cancer"},{"key":"10.2353\/ajpath.2010.100105_bib88","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1002\/ijc.24028","article-title":"Functional significance of VEGFR-2 on ovarian cancer cells","volume":"124","author":"Spannuth","year":"2009","journal-title":"Int J Cancer"},{"key":"10.2353\/ajpath.2010.100105_bib89","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/ijc.23963","article-title":"Autocrine VEGF-A\/KDR loop protects epithelial ovarian carcinoma cells from anoikis","volume":"124","author":"Sher","year":"2009","journal-title":"Int J Cancer"},{"key":"10.2353\/ajpath.2010.100105_bib90","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1200\/JCO.2007.12.1939","article-title":"Phase II clinical trial of bevacizumab and low-dose metronomic oral cyclophosphamide in recurrent ovarian cancer: a trial of the california, chicago, and princess hospital phase II consortia","volume":"26","author":"Garcia","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.2353\/ajpath.2010.100105_bib91","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1093\/jnci\/84.23.1793","article-title":"Clonal origin of epithelial ovarian carcinoma: analysis by loss of heterozygosity, p53 mutation, and X-chromosome inactivation","volume":"84","author":"Jacobs","year":"1992","journal-title":"J Natl Cancer Inst"},{"key":"10.2353\/ajpath.2010.100105_bib92","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0002-9440(10)63306-8","article-title":"Differential gene expression in ovarian carcinoma","volume":"165","author":"Hibbs","year":"2004","journal-title":"Am J Pathol"},{"key":"10.2353\/ajpath.2010.100105_bib93","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/sj.bjc.6601603","article-title":"Predicting biomarkers for ovarian cancer using gene-expression microarrays","volume":"90","author":"Adib","year":"2004","journal-title":"Br J Cancer"},{"key":"10.2353\/ajpath.2010.100105_bib94","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.cancergencyto.2004.02.006","article-title":"Genomic analyses of primary and metastatic serous epithelial ovarian cancer","volume":"154","author":"Israeli","year":"2004","journal-title":"Cancer Genet Cytogenet"},{"key":"10.2353\/ajpath.2010.100105_bib95","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1002\/ijc.24148","article-title":"The clonal evolution of metastases from primary serous epithelial ovarian cancers","volume":"124","author":"Khalique","year":"2009","journal-title":"Int J Cancer"},{"key":"10.2353\/ajpath.2010.100105_bib96","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/ng1060","article-title":"A molecular signature of metastasis in primary solid tumors","volume":"33","author":"Ramawamy","year":"2003","journal-title":"Nat Genet"},{"key":"10.2353\/ajpath.2010.100105_bib97","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1073\/pnas.0712345105","article-title":"Comparative lesion sequencing provides insights into tumor evolution","volume":"105","author":"Jones","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.2353\/ajpath.2010.100105_bib98","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ajog.2008.01.004","article-title":"A new model of ovarian carcinogenesis may influence early detection strategies","volume":"198","author":"Burger","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.2353\/ajpath.2010.100105_bib99","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ajog.2008.01.005","article-title":"Early detection and treatment of ovarian cancer: shifting from early stage to minimal volume of disease based on a new model of carcinogenesis","author":"Kurman","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.2353\/ajpath.2010.100105_bib100","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1158\/0008-5472.CAN-04-3931","article-title":"Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer","volume":"65","author":"Bapat","year":"2005","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2010.100105_bib101","doi-asserted-by":"crossref","first-page":"11154","DOI":"10.1073\/pnas.0603672103","article-title":"Ovarian cancer side populations defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness","volume":"103","author":"Szotek","year":"2006","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944010601605?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944010601605?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:48:25Z","timestamp":1762080505000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944010601605"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":101,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S0002944010601605"],"URL":"https:\/\/doi.org\/10.2353\/ajpath.2010.100105","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ovarian Cancer Development and Metastasis","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.2353\/ajpath.2010.100105","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}